Literature DB >> 12027466

The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia.

M K Nasr1, R J McCarthy, J Hardman, A Chalmers, M Horrocks.   

Abstract

OBJECTIVE: to review the current role and results of angioplasty in the management of critical limb ischaemia (CLI) in a single institution.
METHODS: data on 526 patients with 608 ischaemic limbs, treated between January 1994 and December 1999 was collected prospectively and analysed retrospectively. Patients were divided into 3 groups according to the date of presentation: group 1 (1994-95), group 2 (1996-97) and group 3 (1998-99). The groups were comparable in terms of demographics, mode of presentation and level of disease.
RESULTS: Revascularisation was attempted in 87%, 81% and 91% for groups 1, 2 and 3 respectively (NS). Primary percutaneous transluminal angioplasty (PTA) rates increased from 44% (1994-95) to 69% (1998-99) (p < 0.001), and surgical revascularisation rates decreased correspondingly (p<0.01). Overall cumulative patient survival and limb salvage rates were 82% and 89% for 1 year and 45% and 87% for 5 years, respectively. No statistically significant difference existed between the three groups regarding patient survival, limb salvage rates and mean hospital stay (19, 12 and 12 days, respectively).
CONCLUSION: PTA is increasingly replacing bypass surgery in the treatment of CLI, without compromising patient survival or limb salvage rates. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12027466     DOI: 10.1053/ejvs.2002.1615

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  8 in total

1.  [S3 guidelines for diagnostics and treatment of peripheral arterial occlusive disease].

Authors:  P Huppert; J Tacke; H Lawall
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

Review 2.  [Chronic critical ischemia of the lower leg: pretherapeutic imaging and methods for revascularization].

Authors:  M Treitl; V Ruppert; A K Mayer; C Degenhart; M Reiser; J Rieger
Journal:  Radiologe       Date:  2006-11       Impact factor: 0.635

Review 3.  Contemporary treatment for critical ischemia: the evidence for interventional radiology or surgery.

Authors:  Keith Hussey; Sivanathan Chandramohan
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

4.  The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries.

Authors:  Aleksander Falkowski; Wojciech Poncyljusz; Grazyna Wilk; Małgorzata Szczerbo-Trojanowska
Journal:  Eur Radiol       Date:  2008-11-26       Impact factor: 5.315

5.  Systematic Review and Proportional Meta-Analysis of Endarterectomy and Endovascular Therapy with Routine or Selective Stenting for Common Femoral Artery Atherosclerotic Disease.

Authors:  Khalid Hamid Changal; Mubbasher Ameer Syed; Tawseef Dar; Muhammad Asif Mangi; Mujeeb Abdul Sheikh
Journal:  J Interv Cardiol       Date:  2019-04-14       Impact factor: 2.279

6.  Lin28a up-regulation is associated with the formation of restenosis via promoting proliferation and migration of vascular smooth muscle cells.

Authors:  Zhiwei Zou; Xiaojun Zhou; Ruzhen Zhang; Qian Zhang; Shan Jiang; Chunmei Xu; Rui Zhang; Tianyue Xie; Huangao Zhu; Piyun Gong; Dongmei Zhang; Huimei Ma; Lin Liao; Jianjun Dong
Journal:  J Cell Mol Med       Date:  2020-07-25       Impact factor: 5.310

7.  Evaluation of a new balloon catheter for difficult calcified lesions in infrainguinal arterial disease: outcome of a multicenter registry.

Authors:  G J Spaargaren; M J Lee; J A Reekers; H van Overhagen; L J Schultze Kool; Y L Hoogeveen
Journal:  Cardiovasc Intervent Radiol       Date:  2008-07-26       Impact factor: 2.740

Review 8.  Current evidence of drug-elution therapy for infrapopliteal arterial disease.

Authors:  Stavros Spiliopoulos; Nikiforos Vasiniotis Kamarinos; Elias Brountzos
Journal:  World J Cardiol       Date:  2019-01-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.